Concord Wealth Partners Seagen Inc. Transaction History

Concord Wealth Partners

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$117.37 - $139.17 $2,934 - $3,479	25 New	25 $3,000
Q2 2022 Aug 04, 2022	SELL	$108.81 - $179.33 $5,114 - $8,428	-47 Reduced 65.28%	25 $4,000
Q1 2022 Apr 20, 2022	BUY	$119.61 - $157.85 $956 - $1,262	8 Added 12.5%	72 $10,000
Q4 2021 Jan 21, 2022	BUY	$142.57 - $190.86 $8,411 - $11,260	59 Added 1180.0%	64 $10,000
Q3 2021 Nov 09, 2021	BUY	$142.45 - $169.82 $712 - $849	5 New	5 $1,000
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $687 - $954	-5 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $823 - $1,059	5 New	5 $1,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.